Biochemistry, Apolipoprotein B


Article Author:
Sridevi Devaraj


Article Editor:
Ishwarlal Jialal


Editors In Chief:
Jasleen Jhajj
Cliff Caudill
Evan Kaufman


Managing Editors:
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Frank Smeeks
Kristina Soman-Faulkner
Benjamin Eovaldi
Radia Jamil
Sobhan Daneshfar
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Hajira Basit
Phillip Hynes


Updated:
2/16/2019 10:12:58 AM

Introduction

Lipids such as cholesterol are insoluble in plasma and for delivery to tissues such as the adrenal gland, gonads etc, they have to be packaged into lipoproteins with cholesterol esters and triglycerides in the core and phospholipids, free cholesterol and apolipoproteins on the surface. Such is the composition of the lipoproteins.[1]  Apolipoprotein B (ApoB) is the primary apolipoprotein and is the carrier for the following lipids: chylomicrons, low-density lipoprotein ( LDL), very low-density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and lipoprotein (a).  ApoB is not found in high-density lipoproteins (HDL), the latter are reconstituted into lipoproteins with Apo A.  Hepatic ApoB has a molecular mass of 540000 Da.  There are two circulating forms of Apo B, Apo B48 (from the small intestine) and Apo B100 (from the liver).[1] Intestinal ApoB which is present in chylomicrons has a molecular mass 48% of that of hepatic ApoB.  Hence, hepatic ApoB is termed ApoB100 and intestinal Apo B as apoB 48. The same gene codes for both ApoB48 an ApoB 100.  Apo B-100 contains 4536 amino acids and is necessary for assembly of VLDL in the liver an also serves as the primary ligand for LDL receptor medicated clearance of LDL particles from the blood. Apo B-48 has 2512 amino acids and is essential for the formation of chylomicrons and serves in the absorption of dietary fats from the intestine.

Fundamentals

ApoB-100 carrying particles such as LDL and lipoprotein (a) predispose to premature atherosclerotic disease (ASCVD)

Issues of Concern

Measurement: Currently available methods for apo B measurement include automated immunoassays. Reference material is available that has allowed for standardization of Apo B measurements.  The bias and imprecision for 22 immunonephelometric and immunoturbidimetric assays ranged were usually below 5%.[2] An additional advantage to measuring Apo B as opposed to the standard lipid profile is that a fasting specimen is not required. However despite the availability of accurate and precise methods for Apo B measurement the test is not as widely available or as routinely utilized as the traditional tests of the lipid profile such as total cholesterol and LDL-C measurement/estimation.  This could be due to the cost of testing, unavailability of immunoassay platforms in all clinical laboratories compared to chemistry platforms, lack of consensus guidelines that make Apo B measurements mandatory and it may be that further patient and physician education is necessary with regards to the utility of the test as well as the availability of common target goals. 

There is much recent interest in the role of remnant particles in ASCVD.  Assaying Apo B48 serves as a reliable measure of chylomicron remnants.

Apolipoprotein A acts as a surrogate marker of HDL plasma concentration and evidence of the utility of the ApoB: Apo A ratio as a predictor of cardiovascular disease (CVD) has been reported, especially in the INTERHEART study. However, given the controversy about the role of HDL in preventing atherosclerosis, there is no strong indication to measure apoA.

The estimated non-HDL-C, i.e., total cholesterol minus HDL cholesterol has received strong backing as a predictor of CVD providing similar information as ApoB measurement.  However, while there is a correlation between the two measures, discordance has been noted particularly in patients with dyslipoproteinemias; thus they should not be considered as equivalent measures.  Nonetheless, when measurement of LDL-C is unreliable as with hypertriglyceridemia non-HDL-cholesterol is a valuable adjunct to monitoring therapy. 

Molecular

The gene coding for apo B is located on the short arm of chromosome 2 and consists of 29 exons. This gene codes for both apo B-100, with 4536 amino acids (550 kDa) as well as for apo B-48 (265 kDa) - the latter is only about half the length of the native apo B-100 molecule. The formation of Apo B-48 occurs in the small intestine occurs through a unique mRNA editing process, a highly specific post-transcriptional cytidine deamination using an Apo B mRNA editing enzyme, called apobec-1.[2]

Function

Apolipoprotein B-100 is the protein determinant on LDL that recognizes the apoB/E (LDL) receptor; this recognition of the receptor results in the receptor-mediated catabolism of LDL. There is a single molecule of Apo B per LDL particle.

Testing

Immunonephelometry is the most common means for measurement of apolipoprotein B. Tests for ApoB are now standardized and calibrated to the World Health Organization certified reference materials. However, the AHA/ACC guidelines do not recommend this as a target for treatment. 

Pathophysiology

Familial defective apo B is an autosomal dominant disorder that arises due to a mutation in apo B that prevents binding of the defective apo B to the LDL receptor. This condition results in a clinical phenotype similar to classical familial hypercholesterolemia due to mutations in the LDL receptor with increased LDL-cholesterol, xanthomas and premature ASCVD underscoring the importance of apoB in atherogenesis. The most frequent variant is apoB-3500 caused by a point mutation resulting in a substitution of glutamine for arginine at position 3500.[1] This mutation is an excellent illustration of a defect in an important ligand resulting in premature ASCVD. 

Clinical Significance

The assessment of cardiovascular disease has for the last several decades has had its basis on the findings of the Framingham Heart Study cohorts with emphasis on total cholesterol and low-density lipoprotein cholesterol (LDL-C).[3][1] Apo B is a component of all atherogenic or potentially atherogenic particles, including small  very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), LDL, and lipoprotein(a) [Lp(a)], and each particle contains 1 molecule of apo B. Therefore, apo B provides a direct measure of the number of atherogenic lipoprotein particles in the circulation.

ApoB containing lipoproteins play a crucial role in atherogenesis including promoting plaque formation within arteries.  Many studies in the recent past have demonstrated that increased levels of apoB are a better predictor of risk for cardiovascular disease (CVD)  than the aforementioned traditional markers.  Measurement of ApoB serves as a direct indicator of the number of circulating atherogenic particles. Importantly, there is one Apo B molecule per hepatic derived lipoprotein particle. Additionally,  in some studies, ApoB measurement improves CVD risk prediction in diabetes patients and those with metabolic syndrome.[4] Apart from the role as a prediction marker for CVD risk, measurement of Apo B  levels may be used to monitor risk in patients following initiation of statin therapy.[2][[3] However common treatment goals as available for LDL-c need to be established for ApoB. Since each Apo B containing lipoprotein particle only contains one apoB molecule, the measurement of apoB also provides a measure of particle number

ApoB also acts as a ligand for LDL receptor-mediated clearance.  Mutations affecting ApoB such as in familial defective apoB result in familial hypercholesterolemia.  On the other hand, familial hypobetalipoproteinemia is an inherited disorder associated with low LDL levels and results from mutations in the Apo B gene. There are no apparent clinical sequelae with this disorder, but Vitamin E deficiency could develop and hence supplementation is the usual recommendation. 

 A promising new area in lipid-lowering therapies is that of antisense oligonucleotides to target mRNA of proteins that are involved in cholesterol metabolism. Initial trials of apoB antisense oligos have shown promise with a 50% reduction in Apo B levels, 30% reduction in LDL levels and decreased cardiovascular risk.  However, they cause liver dysfunction. A new goal of the 2018 NCEP guidelines is the inclusion of apoB, stating that an apoB greater than 130 mg/dL is a risk-enhancing factor and requires measurement in primary prevention treatment protocols and this is an essential step towards the analysis of apoB for cardiovascular risk.[5]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Biochemistry, Apolipoprotein B - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following lipoprotein types is only found on chylomicrons?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Apolipoproteins are proteins that combine with lipids to form lipoproteins such as HDL, LDL, VLDL, and chylomicrons. Which of the following apolipoprotein is involved in forming LDL and VLDL?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A diabetic male is in the clinic for his monthly blood work. Hs is a heavy smoker, has hypertension, and arthritis. He has always been non-compliant with his medications, and he does not exercise. Last month he was assessed by the cardiologist and deemed to be at moderate to high-risk for heart disease. Based on guidelines by the American College of Endocrinology, the patient should attain an apolipoprotein B (apoB) goal of less than?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 55-year-old male has severe hypercholesterolemia with an LDL-cholesterol of 230mg/dL. He also has a family history of hypercholesterolemia. Genetic studies do not reveal any mutation defect in the LDL receptor gene. Which is the next most frequent cause of this familial hypercholesterolemia?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which apolipoprotein is integral for the synthesis and structure of chylomicrons?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Biochemistry, Apolipoprotein B - References

References

Jialal I,Barton Duell P, Diagnosis of Familial Hypercholesterolemia. American journal of clinical pathology. 2016 Apr     [PubMed]
Contois JH,McConnell JP,Sethi AA,Csako G,Devaraj S,Hoefner DM,Warnick GR, Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clinical chemistry. 2009 Mar     [PubMed]
Jialal I, A practical approach to the laboratory diagnosis of dyslipidemia. American journal of clinical pathology. 1996 Jul     [PubMed]
    [PubMed]
    [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Optometry-Basic Science. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Optometry-Basic Science, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Optometry-Basic Science, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Optometry-Basic Science. When it is time for the Optometry-Basic Science board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Optometry-Basic Science.